MITF and gastrointestinal stromal tumor: Moreover, 63.5% of MITF targets in GIST-T1 and 65.5% in GIST48 overlapped with H3K27ac-marked active chromatin, indicating that MITF preferentially binds active enhancer elements in both lines.